Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Purpose: To investigate the association between cigarette smoking, alcohol consumption, and esophageal adenocarcinoma survival, including stratified analysis by selected prognostic biomarkers. Methods: A population-representative sample of 130 esophageal adenocarcinoma patients (n = 130) treated at the Northern Ireland Cancer Centre between 2004 and 2012. Cox proportional hazards models were applied to evaluate associations between smoking status, alcohol intake, and survival. Secondary analyses investigated these associations across categories of p53, HER2, CD8, and GLUT-1 biomarker expression. Results: In esophageal adenocarcinoma patients, there was a significantly increased risk of cancer-specific mortality in ever, compared to never, alcohol drinkers in unadjusted (HR 1.96 95% CI 1.13–3.38) but not adjusted (HR 1.70 95% CI 0.95–3.04) analysis. This increased risk of death observed for alcohol consumers was more evident in patients with normal p53 expression, GLUT-1 positive or CD-8 positive tumors. There were no significant associations between survival and smoking status in esophageal adenocarcinoma patients. Conclusions: In esophageal adenocarcinoma patients, cigarette smoking or alcohol consumption was not associated with a significant difference in survival in comparison with never smokers and never drinkers in fully adjusted analysis. However, in some biomarker-selected subgroups, ever-alcohol consumption was associated with a worsened survival in comparison with never drinkers. Larger studies are needed to investigate these findings, as these lifestyle habits may not only be linked to cancer risk but also cancer survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The role of lifestyle factors in relation to survival remains uncertain, with a handful of studies to date investigating associations with obesity, smoking, physical activity, diet, or medications.”
From Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center (2021) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
van Hagen, P., Hulshof, M. C. C. M., van Lanschot, J. J. B., Steyerberg, E. W., Henegouwen, M. I. V. B., Wijnhoven, B. P. L., Richel, D. J., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112088 · Cited by 5,521
Shapiro, J., van Lanschot, J. J. B., Hulshof, M. C. C. M., van Hagen, P., van Berge Henegouwen, M. I., Wijnhoven, B. P. L., van Laarhoven, H. W. M., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00040-6 · Cited by 2,565
Pennathur, A., Gibson, M. K., Jobe, B. A., & Luketich, J. D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60643-6 · Cited by 2,390
Global incidence of oesophageal cancer by histological subtype in 2012
Arnold, M., Soerjomataram, I., Ferlay, J., & Forman, D. (2015) · Gut · doi:10.1136/gutjnl-2014-308124 · Cited by 1,423
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001216 · Cited by 1,013
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
Altman, D. G., McShane, L. M., Sauerbrei, W., & Taube, S. E. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-51 · Cited by 372
Cook, M. B., Kamangar, F., Whiteman, D. C., Freedman, N. D., Gammon, M. D., Bernstein, L., Brown, L. M., Risch, H. A., Ye, W., Sharp, L., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq289 · Cited by 316
Ahrendt, S. A., Chow, J. T., Yang, S. C., Li, W., Zhang, M. J., Jen, J., & Sidransky, D. (2000) · PubMed · Cited by 142
HER2 testing in the UK: further update to recommendations
Walker, R. A., Bartlett, J., Dowsett, M., Ellis, I. O., Hanby, A. M., Jasani, B., Miller, K., & Pinder, S. E. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.054866 · Cited by 135
Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium
Freedman, N. D., Murray, L. J., Kamangar, F., Abnet, C. C., Cook, M. B., Nyrén, O., Ye, W., Wu, A. H., Bernstein, L., Brown, L. M., et al. (2011) · Gut · doi:10.1136/gut.2010.233866 · Cited by 116
Hamada, T., Keum, N., Nishihara, R., & Ogino, S. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-016-1272-3 · Cited by 114
Noble, F., Mellows, T., McCormick Matthews, L. H., Bateman, A. C., Harris, S., Underwood, T. J., Byrne, J. P., Bailey, I. S., Sharland, D. M., Kelly, J. J., et al. (2016) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-016-1826-5 · Cited by 109
Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers
Trivers, K. F., de Roos, A. J., Gammon, M. D., Vaughan, T. L., RISCH, H., Olshan, A. F., SCHOENBERG, J., Mayne, S. T., Dubrow, R., Stanford, J. L., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00613-5 · Cited by 77
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer
Boyle, D. P., McArt, D. G., Irwin, G. W., Wilhelm-Benartzi, C. S., Lioe, T. F., Sebastián, E., McQuaid, S., Hamilton, P. W., James, J. A., Mullan, P. B., et al. (2014) · Histopathology · doi:10.1111/his.12398 · Cited by 77
Self-citationSundelöf, M., Lagergren, J., & Ye, W. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.04.002 · Cited by 75
Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis
Zheng, X. W., Song, X., Shao, Y., Xu, B., Hu, W., Zhou, Q., Chen, L., Zhang, D., Wu, C., & Jiang, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487164 · Cited by 69
Curtis, N. J., Noble, F., Bailey, I. S., Kelly, J. J., Byrne, J. P., & Underwood, T. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23484 · Cited by 67
HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.
Gowryshankar, A., Nagaraja, V., & Eslick, G. D. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2013.039 · Cited by 55
Matthews, L. H. M., Noble, F., Tod, J., Jaynes, E., Harris, S., Primrose, J. M., Ottensmeier, C. H. H., Thomas, G. J., & Underwood, T. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.179 · Cited by 49
Rice, T. W., & Blackstone, E. H. (2013) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2013.07.004 · Cited by 45
Hirko, K. A., Chen, W. Y., Willett, W. C., ROSNER, B. A., Hankinson, S. E., Beck, A. H., Tamimi, R. M., & Eliassen, A. H. (2015) · International Journal of Cancer · doi:10.1002/ijc.29861 · Cited by 44
Do smoking and alcohol behaviours influence GI cancer survival?
McMenamin, Ú. C., McCain, S., & Kunzmann, A. T. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.015 · Cited by 43
The Northern Ireland Biobank: A Cancer Focused Repository of Science
Lewis, C. E., McQuaid, S., Clark, P., Murray, P., McGuigan, T., Greene, C., Coulter, B., Mills, K., & James, J. A. (2018) · Open Journal of Bioresources · doi:10.5334/ojb.47 · Cited by 36
Self-citationOver expression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas
Fléjou, J., Muzeau, F., Potet, F., Pelletier, F. L., FEKETE, F., & Hénin, D. (1994) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80440-1 · Cited by 34
Thrift, A. P., Nagle, C. M., Fahey, P. P., Smithers, B. M., Watson, D. I., & Whiteman, D. C. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9913-1 · Cited by 29
Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma
Blayney, J. K., Cairns, L., Li, G., McCabe, N., Stevenson, L. S., Peters, C. J., Reid, N. B., Spence, V. J., Chisambo, C., McManus, D. T., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24906 · Cited by 24
Self-citationEarly adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival
Spreafico, A., Coate, L., Zhai, R., Xu, W., Chen, Z.-F., Chen, Z., Patel, D., Tse, B., Brown, M. C., Heist, R. S., et al. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2016.11.009 · Cited by 19
Association Between Smoking and p53 Mutation in Oesophageal Squamous Cell Carcinoma: A Meta-analysis
Wu, X., Zheng, Y., Tang, M., Li, X., Zeng, R., & Zhang, J. R. (2015) · Clinical Oncology · doi:10.1016/j.clon.2015.02.007 · Cited by 12
Cited by
Wang, M., Li, Y., Xiao, Y., Yang, M., Chen, J., Jian, Y., Chen, X., Shi, D., Chen, X., Ouyang, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27348-8 · Cited by 58
Li, Y., Wang, M., Yang, M., Xiao, Y., Jian, Y., Shi, D., Chen, X., Ouyang, Y., Kong, L., Huang, X., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4160 · Cited by 35
Esophageal cancer: Treatment advances and need for screening
Eisner, D. C. (2024) · JAAPA · doi:10.1097/01.jaa.0001007328.84376.da · Cited by 34
Impact of Lifestyle Modifications on Cancer Mortality: A Systematic Review and Meta-Analysis
Rabbani, S. A., Patni, M. A., El‐Tanani, M., Rangraze, I. R., Wali, A. F., Babiker, R. A., Satyam, S. M., El‐Tanani, Y., & Almetwally, A. A. M. S. (2025) · Medicina · doi:10.3390/medicina61020307 · Cited by 31
Bona, D., Manara, M., Bonitta, G., Guerrazzi, G., Guraj, J., Lombardo, F., Biondi, A., Cavalli, M., Bruni, P. G., Campanelli, G., et al. (2024) · Cancers · doi:10.3390/cancers16081468 · Cited by 25
Metadata
- Authors
- McCain, R. S., McManus, D. T., McQuaid, S., James, J. A., Salto-Tellez, M., Reid, N. B., Craig, S., Chisambo, C., Bingham, V., McCarron, E., Parkes, E., Turkington, R. C., & Coleman, H. G.
- Affiliations
- Queen's University Belfast (GB)
- Belfast Health and Social Care Trust (GB)
- Corresponding author
- McCain, R. Stephen
- ORCID
- Venue
- Cancer Causes & Control
- Published
- 2019-11-30
- Volume
- 31
- Issue
- 1
- Pages
- 1-11
- ISSN
- 0957-5243 (ISSN-L)
- 1573-7225
- PMC
- PMC6942597
- OpenAlex
- W2990214204
- Cited by
- 28
- References
- 29
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 7 · 2021: 6 · 2020: 2
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cancer Causes & Control (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- Funders
- Cancer Research UK (C11512/A20256 to PWH/MS-T)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- esophageal adenocarcinoma, alcohol consumption, cigarette smoking, cancer survival, cancer-specific mortality, p53 expression, HER2 expression, CD8 expression, GLUT1 expression, prognostic factors, lifestyle factors
- MeSH terms
- Tobacco Smoking, Adenocarcinoma, Adult, Aged, Alcohol Drinking, Esophageal Neoplasms, Female, Humans, Life Style, Male, Middle Aged, Northern Ireland, Prognosis, Risk Factors, Smoking, Cohort Studies, Proportional Hazards Models, Tumor Suppressor Protein p53, CD8 Antigens, Chemotherapy, Adjuvant, Erb-b2 Receptor Tyrosine Kinases, Neoadjuvant Therapy, Tissue Array Analysis, Glucose Transporter Type 1, Pathology, Molecular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
